Fluoroscopy Time, Patient Dose, and Staff Protection During a Complex Intervention
A 68-year-old man (BMI 34) is undergoing a complex, calcified LAD PCI via femoral access. The procedure is prolonged, with multiple cine runs and steep LAO cranial views. The lab's dose display shows the air kerma is rising faster than expected, and the operator notes the image is noisy in the steep views. The patient's skin in the beam field is beginning to look erythematous near the end of the case. The team must manage radiation dose while completing the procedure safely.
1. What factors are increasing the patient's radiation dose, and how should the team reduce it in real time?
Read the worked answer
Contributors include large patient habitus (more scatter and higher exposure), steep LAO cranial views (longer beam path, more attenuation), prolonged fluoroscopy and multiple cine runs, and magnification. Real-time reduction strategies: (1) use pulsed fluoroscopy at the lowest adequate frame rate and avoid continuous fluoroscopy; (2) collimate tightly to the region of interest; (3) avoid magnification unless necessary; (4) use stored fluoroscopy and limit cine runs; (5) change projection angles to reduce beam path through thick tissue; (6) keep the image intensifier/detector close to the patient and the tube farther away; (7) use last-image hold rather than live fluoroscopy; (8) consider IVUS to reduce angiographic runs. Monitor air kerma and dose-area product against institutional thresholds.
2. The patient's skin is erythematous in the beam field. What does this suggest, and what follow-up is required?
Read the worked answer
Erythema during or shortly after a prolonged procedure suggests radiation-induced skin injury, which can range from transient erythema to more significant injury depending on the peak skin dose. The team should: (1) record the total air kerma and dose-area product and estimate peak skin dose; (2) document the beam entry site(s) and the duration of exposure; (3) notify the radiation safety officer and, per institutional policy, the patient's care team; (4) provide skin care instructions and arrange follow-up (e.g., dermatology or wound care) if the dose is high; (5) counsel the patient about avoiding sun exposure and reporting blistering or ulceration. High-dose cases may require reporting to regulatory bodies per local rules. The key is documentation and follow-up, not just reassurance.
3. What staff protection measures should be emphasized during this prolonged case?
Read the worked answer
Staff protection: (1) maximize distance from the patient and the primary beam; (2) use ceiling-mounted and table-mounted shields, including a radiation-absorbing drape if available; (3) wear lead aprons and thyroid shields and leaded eyewear; (4) use dosimeters and monitor badges; (5) keep hands out of the primary beam and use collimation to reduce scatter; (6) rotate staff if possible to limit individual dose; (7) ensure proper collimation and detector positioning to reduce scatter; (8) review fluoroscopy time and dose at case end. The team should also consider whether the case can be staged or whether alternative imaging (IVUS) can reduce fluoroscopy time.